BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1538876)

  • 21. [The amnioinfusion therapy of saline solution for premature rupture of the membranes before 27 weeks' gestational age].
    Horibe N; Ishikawa K; Kosaki H; Hashiba Y; Kuno N; Ito H; Miwa S; Ochi M; Fujimura Y; Kimura T
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):1023-9. PubMed ID: 8371017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic amnioinfusion in pregnancies complicated by thick meconium.
    Eriksen NL; Hostetter M; Parisi VM
    Am J Obstet Gynecol; 1994 Oct; 171(4):1026-30. PubMed ID: 7943066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective, randomized evaluation of intrapartum amnioinfusion. Fetal acid-base status and cesarean delivery.
    MacGregor SN; Banzhaf WC; Silver RK; Depp R
    J Reprod Med; 1991 Jan; 36(1):69-73. PubMed ID: 2008006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Collaborative Randomised Amnioinfusion for Meconium Project (CRAMP): 1. South Africa.
    Hofmeyr GJ; Gülmezoğlu AM; Buchmann E; Howarth GR; Shaw A; Nikodem VC; Cronje H; de Jager M; Mahomed K
    Br J Obstet Gynaecol; 1998 Mar; 105(3):304-8. PubMed ID: 9532991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic intrapartum amnioinfusion in patients with preterm premature rupture of membranes.
    Nageotte MP; Freeman RK; Garite TJ; Dorchester W
    Am J Obstet Gynecol; 1985 Nov; 153(5):557-62. PubMed ID: 3904456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevention of meconium aspiration in labor using amnioinfusion.
    Wenstrom KD; Parsons MT
    Obstet Gynecol; 1989 Apr; 73(4):647-51. PubMed ID: 2927860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transabdominal amnioinfusion treatment of severe oligohydramnios in preterm premature rupture of membranes at less than 26 gestational weeks.
    De Santis M; Scavo M; Noia G; Masini L; Piersigilli F; Romagnoli C; Caruso A
    Fetal Diagn Ther; 2003; 18(6):412-7. PubMed ID: 14564111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amnioinfusion for prevention of pulmonary hypoplasia in second-trimester rupture of membranes.
    Vergani P; Locatelli A; Strobelt N; Mariani S; Cavallone M; Arosio P; Ghidini A
    Am J Perinatol; 1997 Jul; 14(6):325-9. PubMed ID: 9217952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic versus therapeutic amnioinfusion for oligohydramnios in labour.
    Hofmeyr GJ
    Cochrane Database Syst Rev; 2000; (2):CD000176. PubMed ID: 10796170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic transabdominal amnioinfusion in oligohydramnios for preterm premature rupture of membranes: increase of amniotic fluid index during latency period.
    Garzetti GG; Ciavattini A; De Cristofaro F; La Marca N; Arduini D
    Gynecol Obstet Invest; 1997; 44(4):249-54. PubMed ID: 9415523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amnioinfusion in women with previous cesarean births: a preliminary report.
    Ouzounian JG; Miller DA; Paul RH
    Am J Obstet Gynecol; 1996 Feb; 174(2):783-6. PubMed ID: 8623822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Collaborative Randomised Amnioinfusion for Meconium Project (CRAMP): 2. Zimbabwe.
    Mahomed K; Mulambo T; Woelk G; Hofmeyr GJ; Gülmezoğlu AM
    Br J Obstet Gynaecol; 1998 Mar; 105(3):309-13. PubMed ID: 9532992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The experience of amnioinfusion for oligohydramnios during the early second trimester.
    Hsu TL; Hsu TY; Tsai CC; Ou CY
    Taiwan J Obstet Gynecol; 2007 Dec; 46(4):395-8. PubMed ID: 18182345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perinatal management of meconium staining of the amniotic fluid.
    Holtzman RB; Banzhaf WC; Silver RK; Hageman JR
    Clin Perinatol; 1989 Dec; 16(4):825-38. PubMed ID: 2686889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrapartum amnioinfusion for meconium-stained amniotic fluid: a systematic review of randomised controlled trials.
    Sanchez-Ramos L
    BJOG; 2008 Feb; 115(3):409-10; author reply 410. PubMed ID: 18190380
    [No Abstract]   [Full Text] [Related]  

  • 36. Amnioinfusion and the intrauterine prevention of meconium aspiration.
    Dye T; Aubry R; Gross S; Artal R
    Am J Obstet Gynecol; 1994 Dec; 171(6):1601-5. PubMed ID: 7802076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Short-term and long-term fetal heart rate variability after amnioinfusion treatment of oligohydramnios complicated pregnancy].
    Machalski T; Sikora J; Bakon I; Magnucki J; Grzesiak-Kubica E; Szkodny E
    Ginekol Pol; 2001 Dec; 72(12):1107-11. PubMed ID: 11883219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Premature rupture of the membranes at <26 weeks' gestation: role of amnioinfusion in the management of oligohydramnios.
    Vergani P; Locatelli A; Verderio M; Assi F
    Acta Biomed; 2004; 75 Suppl 1():62-6. PubMed ID: 15301294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic amnioinfusion for meconium-stained amniotic fluid.
    Spong CY; Ogundipe OA; Ross MG
    Am J Obstet Gynecol; 1994 Oct; 171(4):931-5. PubMed ID: 7943103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrapartum amnioinfusion for meconium-stained amniotic fluid: a systematic review of randomised controlled trials.
    Jana N; Barik S; Arora N
    BJOG; 2007 Dec; 114(12):1582-3; author reply 1583-4. PubMed ID: 17995503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.